C. Baamonde

发表

Ischemic preconditioning and kidney transplantation: in vivo nitric oxide monitoring in a rat ischemia-reperfusion experimental model.

J. Berrazueta, E. Salas, D. Casanova, 2006, Transplantation proceedings.

G-Protein-Associated Signal Transduction Processes Are Restored after Postweaning Environmental Enrichment in Ts65Dn, a Down Syndrome Mouse Model

M. Dierssen, C. Martínez-Cué, J. Flórez, 2011, Developmental Neuroscience.

2-Hydroxyoleic Acid: A New Hypotensive Molecule

P. Escribá, M. Benet, Silvia Terés, 2004, Hypertension.

Preparation of Cell Membranes From Left Ventricles and Aortas

P. Escribá, M. Benet, Silvia Terés, 2004 .

Antihypertensive action of 2-hydroxyoleic acid in SHRs via modulation of the protein kinase A pathway and Rho kinase Published, JLR Papers in Press, May 10, 2006.

P. Escribá, K. Jakobs, Silvia Terés, 2006, Journal of Lipid Research.

Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome

M. Dierssen, J. Flórez, I. Vallina, 1997, Brain Research.

Membrane Structure Modulation , PKC α Activation and Anti-Cancer Activity of Minerval

P. Escribá, Silvia Terés, Jordi Martínez, 2004 .

Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer’s disease

N. Cairns, M. Dierssen, G. Lubec, 2006, Amino Acids.

Postnatal Handling Induces Long-term Modifications in Central β-noradrenergic Signalling in Rats

M. Dierssen, C. Martínez-Cué, J. Flórez, 2002, Stress.

Short-Term Effects of Postnatal Manipulation on Central β-Adrenoceptor Transmission

M. Dierssen, C. Martínez-Cué, J. Flórez, 1999 .

Membrane Structure Modulation, Protein Kinase Cα Activation, and Anticancer Activity of Minerval

P. Escribá, Silvia Terés, Jordi Martínez, 2005, Molecular Pharmacology.

Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.

X. Estivill, M. Dierssen, E. Martí, 2001, Human molecular genetics.

Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome

M. Dierssen, A. Tobeña, R. M. Escorihuela, 1998, Neuroscience Letters.

A behavioral assessment of Ts65Dn mice: a putative Down syndrome model

M. Dierssen, A. Tobeña, R. M. Escorihuela, 1995, Neuroscience Letters.

Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome

Mara Dierssen, M. Dierssen, M. Davisson, 2002, Behavioural Brain Research.

A murine model for Down syndrome shows reduced responsiveness to pain.

M. Dierssen, C. Martínez-Cué, J. Flórez, 1999, Neuroreport.

Reduced phospholipase C‐β activity and isoform expression in the cerebellum of TS65DN mouse: A model of down syndrome

M. Dierssen, J. Sallés, J. Flórez, 2001, Journal of neuroscience research.

Membrane structure modulation, protein kinase C alpha activation, and anticancer activity of minerval.

P. Escribá, J. Casas, P. Kasprzyk, 2005, Molecular pharmacology.

Membrane Structure Modulation, Protein Kinase Cα Activation, and Anticancer Activity of Minerval

P. Escribá, J. Casas, P. Kasprzyk, 2005, Molecular Pharmacology.

Impaired cyclic AMP production in the hippocampus of a Down syndrome murine model.

M. Dierssen, C. Martínez-Cué, J. Flórez, 1996, Brain research. Developmental brain research.